- CCHF is a dangerous viral disease spread by ticks.
- It can cause sudden fever and internal bleeding.
- Outbreaks happen in parts of the world.
- Scientists tested a new experimental vaccine in mice.
- The vaccine enters cells but cannot make more virus.
- One dose protected animals within only a few days.
- A booster gave stronger and longer protection in mice.
- Scientists still found antibodies in mice after many months.
- Researchers plan large-scale production under strict rules next.
- Human trials will begin only after more tests and approval.
Difficult words
- viral — Related to a virus that makes people sick
- tick — A small blood-sucking animal that bitesticks
- vaccine — A medicine that helps the body fight disease
- dose — A measured amount of a medicine or vaccine
- antibody — A blood protein that fights infectionsantibodies
- outbreak — A sudden start of many disease casesOutbreaks
Tip: hover, focus or tap highlighted words in the article to see quick definitions while you read or listen.
Discussion questions
- Have you ever had a vaccine?
- Do you see ticks where you live?
- Would you wait for approval before trying a new vaccine?
Related articles
Traditional African Diet Reduces Inflammation
A trial in Tanzania found that a traditional plant-based African diet lowered inflammation within two weeks, while a short-term Western diet increased inflammation and weakened immune responses. The results matter for rising non-communicable diseases in Sub-Saharan Africa.
Dopamine helps lock in new skills during sleep
A study from the University of Michigan finds that dopamine neurons become active during NREM sleep soon after a person learns a movement. Their activity, together with sleep spindles, strengthens motor memories and improves skills after sleep.
Do low‑calorie sweeteners affect blood sugar and health?
Researchers reviewed trials and large studies on non‑nutritive sweeteners and found signals of worse blood sugar control and possible metabolic harm. They note questions about mechanisms, study limits, and a need for more trials.
